|
|
|
|
|
|
Heat Biologics Inc (HTBX)
|
|
0.509 +0.009 (+1.780%)
|
8/16/2017 1:08pm
|
|
Open:
|
0.510
|
Pre. Close:
|
0.500
|
|
High:
|
0.510
|
Low:
|
0.500
|
|
Volume:
|
34,361
|
Market Cap:
|
18.13M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
0.52 - 0.53
|
0.53 - 0.54
|
|
Low:
|
0.46 - 0.47
|
0.47 - 0.5
|
|
Close:
|
0.48 - 0.49
|
0.49 - 0.51
|
|
|
|
|
|
|
Technical analysis (as of: 2017-08-16 1:11:26 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 0.61  One year: 0.65
|
|
Support:
|
Support1: 0.46 Support2: 0.38
|
|
Resistance:
|
Resistance1:
0.52 Resistance2: 0.56
|
|
Pivot:
|
0.51
|
|
Moving Averages:
|
MA(5): 0.50  MA(20): 0.51
MA(100): 0.66 MA(250): 0.98
|
|
MACD:
|
MACD(12,26):
-0.02 Signal(12,26,9): -0.02
|
|
%K %D:
|
%K(14,3): 18.48 %D(3): 14.08
|
|
RSI:
|
RSI(14): 42.05
|
|
52-Week:
|
High: 3.350
Low: 0.462 Change(%): -66.5
|
|
Average Vol(K):
|
3-Month: 28626
10-Days 7780
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.HTBX has closed above bottom band by 42.0%. Bollinger Bands are 51.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to HTBX's normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Sat, 10 Oct 2015 11:26:15 GMT
Heat Biologics Has Considerable Upside In Cancer Immunotherapy
Wed, 08 Mar 2017 12:00:00 GMT
Heat Biologics Announces Agreement to Acquire Pelican Therapeutics
Tue, 21 Mar 2017 13:48:38 GMT
Heat Biologics Reports Positive NSCLC Drug Results (HTBX)
Wed, 30 Nov 2016 22:28:16 GMT
Heat Biologics Presents Topline HS-410 Phase 2 Bladder Cancer Results at the ...
Tue, 15 Aug 2017 10:18:45 GMT
Is Heat Biologics Inc (NASDAQ:HTBX) Going to Burn These Institutional Investors?
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
